Your browser doesn't support javascript.
loading
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology.
Patti, Giuseppe; Lio, Veronica; Cavallari, Ilaria; Gragnano, Felice; Riva, Letizia; Calabrò, Paolo; Di Pasquale, Giuseppe; Pengo, Vittorio; Rubboli, Andrea.
Afiliación
  • Patti G; Department of Translational Medicine, "Maggiore della Carità" Hospital, University of Eastern Piedmont, Via Solaroli, 17, 28 100, Novara, Italy. giuseppe.patti@uniupo.it.
  • Lio V; Department of Translational Medicine, "Maggiore della Carità" Hospital, University of Eastern Piedmont, Via Solaroli, 17, 28 100, Novara, Italy.
  • Cavallari I; Campus Bio-Medico University of Rome, Rome, Italy.
  • Gragnano F; "Sant'Anna and San Sebastiano" Hospital of Caserta, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Riva L; "Maggiore" Hospital, Bologna, Italy.
  • Calabrò P; "Sant'Anna and San Sebastiano" Hospital of Caserta, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Di Pasquale G; "Maggiore" Hospital, Bologna, Italy.
  • Pengo V; Campus Biomedico "Pietro d'Abano", University of Padua, Padua, Italy.
  • Rubboli A; Fondazione Arianna" On Anticoagulation, Bologna, Italy.
Am J Cardiovasc Drugs ; 20(6): 559-570, 2020 Dec.
Article en En | MEDLINE | ID: mdl-33145698
In patients with coronavirus disease 2019 (COVID-19), the prevalence of pre-existing cardiovascular diseases is elevated. Moreover, various features, also including pro-thrombotic status, further predispose these patients to increased risk of ischemic cardiovascular events. Thus, the identification of optimal antithrombotic strategies in terms of the risk-benefit ratio and outcome improvement in this setting is crucial. However, debated issues on antithrombotic therapies in patients with COVID-19 are multiple and relevant. In this article, we provide ten questions and answers on risk stratification and antiplatelet/anticoagulant treatments in patients at risk of/with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based on the scientific evidence gathered during the pandemic.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / COVID-19 / Anticoagulantes Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Am J Cardiovasc Drugs Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombosis / COVID-19 / Anticoagulantes Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Am J Cardiovasc Drugs Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Nueva Zelanda